Improved Intraocular Lens Delivery System Released

Article

The enhanced system gives eye care professionals the ability to safely deliver an intraocular lens through incisions as small as 2.2 mm.

Bausch + Lomb today released an enhanced intraocular lens (IOL) loading system, giving eye care professionals the ability to safely deliver its IOL through unenlarged phaco incisions as small as 2.2 mm.

First introduced in February 2014, the BLIS injector system includes a reusable titanium hand piece to deliver the enVista hydrophobic acrylic IOL. Now, the enhanced BLIS system features a softened plunger tip that is 2 mm longer than the older model, allowing for easier placement in the capsular bag.

“As a surgeon who has implanted a substantial number of enVista IOLs using BLIS, it was great to work seamlessly with Bausch and Lomb to further enhance and develop the next-generation BLIS injector system,” said Anil Shivaram, an eye care professional, in a press release. “With the upgraded features in BLIS, I look forward to using this enhanced system with the enVista IOL.”

The enVista IOL is designed to provide long-term eyesight clarity to patients and reduce posterior capsular opacification, which can cause clouded vision after surgery. It is the first and only FDA-approved IOL.

Recent Videos
Image credit:  Gorodenkoff | stock.adobe.com
Sun Screen, Photosensitivity, Pharmacy | Image Credit: sosiukin - stock.adobe.com
Catalyst Trial, Diabetes, Hypertension | Image Credit: grinny - stock.adobe.com
Various healthy foods -- Image credit: New Africa | stock.adobe.com
LGBTQIA+ pride -- Image credit: lazyllama | stock.adobe.com
Modern pharmacy building facade with large window showcasing the interior, as seen from the street view, promoting a welcoming atmosphere for customers. Frontal view. Generative AI - Image credit: Karrrtinki | stock.adobe.com